Holen Sie sich die Stockscreener-App
2.69
8.03%
0.20
Schlusskurs vom Vortag:
$2.49
Offen:
$2.6
24-Stunden-Volumen:
2.98M
Relative Volume:
4.23
Marktkapitalisierung:
$270.52M
Einnahmen:
$447.48M
Nettoeinkommen (Verlust:
$-14.55M
KGV:
-17.93
EPS:
-0.15
Netto-Cashflow:
$7.61M
1W Leistung:
+15.95%
1M Leistung:
+22.83%
6M Leistung:
+79.33%
1J Leistung:
+4.26%
1-Tages-Spanne:
$2.57
$2.95
1-Wochen-Bereich:
$2.15
$2.95
52-Wochen-Spanne:
$1.40
$2.95
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Vergleichen Sie ARAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
2.69 | 270.52M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray Inc (NASDAQ: ARAY): Blank Check On Growth? - Stocks Register
Accuray Incorporated (NASDAQ:ARAY) Q2 2025 Earnings Call Transcript - Insider Monkey
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Prod - GuruFocus.com
Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Product Revenue and Strategic ... - Yahoo Finance
Accuray raises FY 2025 revenue guidance to $463M-$475M, driven by strong China growth - MSN
Accuray Incorporated Shows Improved Financial Performance - TipRanks
Accuray (ARAY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates - MSN
Accuray: Fiscal Q2 Earnings Snapshot - Huron Daily Tribune
Accuray Inc Q2 Earnings: EPS of $0.03 Beats Estimate, Revenue Su - GuruFocus.com
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Accuray Q2 Earnings Summary & Key Takeaways - Benzinga
Accuray Reports Strong Q2 Financial Results for 2025 - TipRanks
Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q2 Revenue $116.2M, vs. FactSet Est of $110.3M - Marketscreener.com
Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance - PR Newswire
Accuray Incorporated (NASDAQ:ARAY) Short Interest Up 12.3% in January - MarketBeat
Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex
A look into Accuray Inc (ARAY)’s deeper side - SETE News
Radiofrequency Ablation Devices For Pain Management Market - openPR
Here's Why You Should Add Accuray Stock in Your Portfolio Now - MSN
Non Melanoma Skin Cancer Market Expected to Reach $911.9 Million - openPR
With 61% ownership, Accuray Incorporated (NASDAQ:ARAY) boasts of strong institutional backing - Yahoo Finance
Accuray Incorporated (NASDAQ:ARAY) Shares Purchased by Assenagon Asset Management S.A. - Defense World
Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product - PR Newswire
Accuray to Report Q2 FY2025 Financial Results on February 5Conference Call Details Announced - StockTitan
Accuray Hires Siemens Healthineers VP Leonel Peralta as COO - MPO-mag
Here's Why You Should Add Accuray Stock to Your Portfolio Now - MSN
Accuray (ARAY) to Release Earnings on Wednesday - MarketBeat
Accuray appoints new chief operations officer - MSN
Leonel Peralta to Join Accuray as Chief Operations Officer - PR Newswire
Global Radiation Oncology Treatment Planning Software Market - openPR
Accuray (ARAY) Shows Fast-paced Momentum But Is Still a Bargain Stock - MSN
Barclays PLC Acquires 104,310 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Fly 25% But Investors Aren't Buying For Growth - Simply Wall St
Radiotherapy Market Generated Opportunities, Future Scope by 2031 | Accuray Incorporated, Elekta , Isoray Inc. - EIN News
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions - Yahoo Finance
Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System - PR Newswire
Why Accuray Incorporated (ARAY) Is Among the Cheap Robotics Stocks to Invest In Now? - Yahoo Finance
Accuray Secures Major China Approval for Revolutionary Cancer Treatment Systems - StockTitan
10 Cheap Robotics Stocks To Invest In Now - Insider Monkey
Jane Street Group LLC Grows Stock Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year? - Yahoo Finance
EDAP Strengthens Board with Former Accuray CEO Josh Levine, Accelerating Robotic HIFU Growth - StockTitan
Geode Capital Management LLC Acquires 45,548 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO - Benzinga
Accuray – There’s Value If Linac Sales Accelerate, But That’s A Big “If” (NASDAQ:ARAY) - Seeking Alpha
Contrasting GlucoTrack (NASDAQ:GCTK) & Accuray (NASDAQ:ARAY) - Defense World
With Accuray Up 16%, Insider Buyers Count Their Returns - Simply Wall St
Radiotherapy Market Future Business Opportunities 2025-2032 | - openPR
Accuray (ARAY) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY) - Yahoo Finance
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.14%
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):